New Enterprise Associates 17, L.P. is an investment firm that reports beneficial ownership of shares in Korro Bio, Inc. (KRRO) and 2 other companies under U.S. securities law. It has submitted 4 SEC insider filings since 2024, most recently in March 2026.
Every role New Enterprise Associates 17, L.P. has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
Korro Bio, Inc. (KRRO)1 filingSpyGlass Pharma, Inc. (SGP)1 filingNeueHealth, Inc. (NEUE)2 filingsUpdated Aug 30, 2026
New Enterprise Associates 17, L.P. files SEC Form 4 reports at Korro Bio, Inc. (KRRO). 4 SEC Form 4 filings on record going back to 2024, most recently on 13 March 2026. Most recent open-market trade: bought $2.30M of KRRO on 13 March 2026. Lifetime open-market purchases: $20.00M. Lifetime open-market sales: $2K. Historical track record: 5/5 stars across 3 tracked purchases.
Every recent SEC Form 4 transaction New Enterprise Associates 17, L.P. has reported, most recent first.
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realized performance after each tracked open-market purchase.
| Metric | Value |
|---|---|
| InsiderAlpha rating | ★★★★★ (5/5) |
| Total purchases tracked | 3 |
| Purchases with forward-return data | 3 |
| 30-day win rate | 100% |
| 90-day win rate | 0% |
| Avg 5-day return | +8.43% |
| Avg 30-day return | +10.46% |
| Avg 90-day return | -8.25% |
| Best 30-day return |
InsiderAlpha's records for New Enterprise Associates 17, L.P. go back to 2024: 4 primary Form 4 filings, an average of 1.3 per year. The typical open-market purchase is $5.00M (4 buys totaling $20.00M). The largest single buy on record is $15.00M of SGP in 2026. Sales side: 1 recorded sale totaling $2K, so the filing history runs buy-heavy by dollar value. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Insiders who reported open-market trades in the last 12 months at the companies New Enterprise Associates 17, L.P. files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
New Enterprise Associates 17, L.P. is an investment firm of Korro Bio, Inc. (KRRO). InsiderAlpha holds 4 primary Form 4 filings for it, the earliest from 2024, updated as new SEC EDGAR filings are processed.
The most recent primary Form 4 on record is dated 13 March 2026, one of 4 filings going back to 2024.
Recorded transactions: 4 open-market purchases ($20.00M) and 1 open-market sale ($2K) across all tracked filings.
Across 3 tracked purchases, New Enterprise Associates 17, L.P. averaged +10.5% avg 30-day return with a 100% 30-day win rate. InsiderAlpha rates the track record at 5/5 stars.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
$SGP SpyGlass Pharma, Inc.738.0K shares @ --
| +13.94% |